• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主血液生物标志物用于亚临床和初期结核病:印度南部成人结核病家庭接触者的前瞻性研究。

Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India.

机构信息

Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, Faculty of Medicine, University of Bergen, Bergen, Norway.

Department of Microbiology, Haukeland University Hospital, University of Bergen, Bergen, Norway.

出版信息

Front Immunol. 2023 Jan 11;13:1051963. doi: 10.3389/fimmu.2022.1051963. eCollection 2022.

DOI:10.3389/fimmu.2022.1051963
PMID:36713386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9876034/
Abstract

A large proportion of the global tuberculosis (TB) burden is asymptomatic and not detectable by symptom-based screening, driving the TB epidemic through continued transmission. Currently, no validated tools exist to diagnose incipient and subclinical TB. Nested within a large prospective study in household contacts of pulmonary TB cases in Southern India, we assessed 35 incipient TB and 12 subclinical TB cases, along with corresponding household active TB cases (n=11), and household controls (n=39) using high throughput methods for transcriptional and protein profiling. We split the data into training and test sets and applied a support vector machine classifier followed by a Lasso regression model to identify signatures. The Lasso regression model identified an 11-gene signature (, and ) that distinguished subclinical TB from incipient TB with a very good discriminatory power by AUCs in both training and test sets. Further, we identified an 8-protein signature comprising b-FGF, IFNγ, IL1RA, IL7, IL12p70, IL13, PDGF-BB, and VEGF that differentiated subclinical TB from incipient TB with good and moderate discriminatory power by AUCs in the training and test sets, respectively. The identified 11-gene signature discriminated well between the distinct stages of the TB disease spectrum, with very good discriminatory power, suggesting it could be useful for predicting TB progression in household contacts. However, the high discriminatory power could partly be due to over-fitting, and validation in other studies is warranted to confirm the potential of the immune biosignatures for identifying subclinical TB.

摘要

很大一部分全球结核病(TB)负担是无症状的,无法通过基于症状的筛查检测到,从而通过持续传播推动了结核病疫情。目前,没有经过验证的工具可以诊断初期和亚临床结核病。在印度南部肺结核病例家庭接触者的一项大型前瞻性研究中,我们评估了 35 例初期结核病和 12 例亚临床结核病病例,以及相应的家庭活动性结核病病例(n=11)和家庭对照(n=39),使用转录组和蛋白质谱的高通量方法。我们将数据分为训练集和测试集,并应用支持向量机分类器和 Lasso 回归模型来识别特征。Lasso 回归模型确定了一个由 11 个基因组成的特征(、和),该特征通过训练集和测试集的 AUC 非常好地区分了亚临床结核病和初期结核病。此外,我们确定了一个由 8 种蛋白质组成的特征,包括 b-FGF、IFNγ、IL1RA、IL7、IL12p70、IL13、PDGF-BB 和 VEGF,该特征通过 AUC 在训练集和测试集分别具有良好和中等的区分能力来区分亚临床结核病和初期结核病。确定的 11 个基因特征很好地区分了结核病疾病谱的不同阶段,具有很好的区分能力,这表明它可能有助于预测家庭接触者中结核病的进展。然而,高区分能力可能部分归因于过度拟合,需要在其他研究中进行验证,以确认免疫生物标志物识别亚临床结核病的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/072d393230be/fimmu-13-1051963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/d315f1db66d0/fimmu-13-1051963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/0ac1d296420e/fimmu-13-1051963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/137a5acce393/fimmu-13-1051963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/46e1417871c9/fimmu-13-1051963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/7436566caeec/fimmu-13-1051963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/072d393230be/fimmu-13-1051963-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/d315f1db66d0/fimmu-13-1051963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/0ac1d296420e/fimmu-13-1051963-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/137a5acce393/fimmu-13-1051963-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/46e1417871c9/fimmu-13-1051963-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/7436566caeec/fimmu-13-1051963-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf18/9876034/072d393230be/fimmu-13-1051963-g006.jpg

相似文献

1
Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India.宿主血液生物标志物用于亚临床和初期结核病:印度南部成人结核病家庭接触者的前瞻性研究。
Front Immunol. 2023 Jan 11;13:1051963. doi: 10.3389/fimmu.2022.1051963. eCollection 2022.
2
Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults.宿主血液 RNA 转录本和蛋白质特征用于成人痰液非依赖性结核病诊断。
Front Immunol. 2021 Feb 4;11:626049. doi: 10.3389/fimmu.2020.626049. eCollection 2020.
3
Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations.利用暴露评分和接触调查识别家庭接触者中的亚临床结核病。
BMC Infect Dis. 2020 Jan 31;20(1):96. doi: 10.1186/s12879-020-4800-y.
4
Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis?改善结核家庭中治疗和预防治疗的措施。免疫诊断的潜力?
Front Immunol. 2022 Mar 17;13:801616. doi: 10.3389/fimmu.2022.801616. eCollection 2022.
5
Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.发现和验证结核病进展的预后蛋白质组学特征:一项前瞻性队列研究。
PLoS Med. 2019 Apr 16;16(4):e1002781. doi: 10.1371/journal.pmed.1002781. eCollection 2019 Apr.
6
Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.在印度安得拉邦和特伦甘纳邦耐药结核病患者的家庭接触者中对利福平敏感和耐药结核病进行主动病例发现——一项系统筛查干预措施。
Indian J Tuberc. 2018 Jul;65(3):218-224. doi: 10.1016/j.ijtb.2018.02.004. Epub 2018 Feb 11.
7
Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys.估算亚临床结核病对传播的贡献:来自患病率调查的个体患者数据分析。
Elife. 2023 Dec 18;12:e82469. doi: 10.7554/eLife.82469.
8
Biomarkers for clinical and incipient tuberculosis: performance in a TB-endemic country.用于临床和潜伏性结核病的生物标志物:在结核病流行国家的表现
PLoS One. 2008 Apr 30;3(4):e2071. doi: 10.1371/journal.pone.0002071.
9
Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea.韩国一项前瞻性队列研究:肺结核患者亚临床疾病的临床特征。
BMC Pulm Med. 2020 Dec 2;20(1):316. doi: 10.1186/s12890-020-01351-z.
10
Tuberculosis screening among persons with diabetes mellitus in Pune, India.印度浦那糖尿病患者的结核病筛查。
BMC Infect Dis. 2017 Jun 2;17(1):388. doi: 10.1186/s12879-017-2483-9.

引用本文的文献

1
Integrating pathogen- and host-derived blood biomarkers for enhanced tuberculosis diagnosis: a comprehensive review.整合病原体和宿主来源的血液生物标志物以增强结核病诊断:全面综述。
Front Immunol. 2024 Aug 9;15:1438989. doi: 10.3389/fimmu.2024.1438989. eCollection 2024.

本文引用的文献

1
Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis?改善结核家庭中治疗和预防治疗的措施。免疫诊断的潜力?
Front Immunol. 2022 Mar 17;13:801616. doi: 10.3389/fimmu.2022.801616. eCollection 2022.
2
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions.结核病和 COVID-19 大流行的交织:人群层面和患者层面的影响、临床表现和纠正干预措施。
Lancet Respir Med. 2022 Jun;10(6):603-622. doi: 10.1016/S2213-2600(22)00092-3. Epub 2022 Mar 23.
3
The definition of tuberculosis infection based on the spectrum of tuberculosis disease.
基于结核病疾病谱的结核感染定义。
Breathe (Sheff). 2021 Sep;17(3):210079. doi: 10.1183/20734735.0079-2021.
4
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study.宿主血液转录组生物标志物对 HIV 感染者肺结核的诊断和预后评估的验证:一项前瞻性诊断和预后准确性研究。
Lancet Glob Health. 2021 Jun;9(6):e841-e853. doi: 10.1016/S2214-109X(21)00045-0. Epub 2021 Apr 13.
5
Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults.宿主血液 RNA 转录本和蛋白质特征用于成人痰液非依赖性结核病诊断。
Front Immunol. 2021 Feb 4;11:626049. doi: 10.3389/fimmu.2020.626049. eCollection 2020.
6
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.生物标志物指导的结核病预防治疗(CORTIS):一项随机对照试验。
Lancet Infect Dis. 2021 Mar;21(3):354-365. doi: 10.1016/S1473-3099(20)30914-2. Epub 2021 Jan 25.
7
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis.结核分枝杆菌疫苗研发及保护性免疫应答相关研究的最新进展
Semin Immunol. 2020 Aug;50:101431. doi: 10.1016/j.smim.2020.101431. Epub 2020 Dec 2.
8
A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children.三种蛋白标志物可区分冈比亚儿童中的结核病与其他呼吸道疾病。
EBioMedicine. 2020 Aug;58:102909. doi: 10.1016/j.ebiom.2020.102909. Epub 2020 Jul 22.
9
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.RISK6,一种结核病风险、诊断和治疗反应的 6 基因转录组特征。
Sci Rep. 2020 May 25;10(1):8629. doi: 10.1038/s41598-020-65043-8.
10
Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations.利用暴露评分和接触调查识别家庭接触者中的亚临床结核病。
BMC Infect Dis. 2020 Jan 31;20(1):96. doi: 10.1186/s12879-020-4800-y.